Stock Events
Stock Events
Features
Business
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Nabriva Therapeutics (NBRVF) Q3 2021 Earnings
NBRVF
9
Nov
Expected
Q4 2020
Q1 2021
Q2 2021
Q3 2021
-1.11
-0.81
-0.51
-0.21
Details
Expected EPS
-0.22
Actual EPS
-0.21
Surprise EPS
0.01
Surprise Percent
+4.55%
Description
Nabriva Therapeutics (NBRVF) has reported earnings of -0.21 per share for Q3 2021.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login
Home
Timeline
Search
Watchlist